The Colt

The Student News Site of Coleytown Middle School

The Colt

The Colt


New Treatment For Sickle-Cell Disease


Sorry, there was an error loading this poll.

New Treatment For Sickle-Cell Disease

Genetic Editing Enters the Medical Scene

The Beginning of an Era

For years, humans have possessed the power to edit genes. The power to change the fundamental nature of a living thing, by changing and splicing the very code that creates them. And now, we are beginning to turn that power away from the typical animal test subjects, and towards our own species. Genetic diseases have plagued humans since our beginning. They were previously thought to be incurable- but genetic editing could change that.

What is Sickle Cell Disease?

On December 8, 2023, the FDA officially approved two groundbreaking genetic treatments for sickle-cell disease. Let’s break that down. Sickle-cell disease is a relatively rare genetic condition that affects roughly 100,000 people in the US. It causes the red blood cells in your bloodstream to form, instead of the usual doughnut, a more crescent-like shape. It sounds harmless in and of itself. However, instead of making a nice, comfy pillow for oxygen to rest on, it’s… well… not. Sickle-cell disease restricts blood flow, because the oxygen simply can’t be carried around as efficiently in their deformed state. And that’s just the first domino in an often fatal chain of events. Without proper oxygenation, the organs suffer serious damage, Severe pain is almost constant. If organ damage continues, it will most likely leave the victim either permanently disabled or dead.

Casgevy’s Significance

Help is on the horizon, though. This December, the FDA approved Lyfgenia and Casgevy, two distinct treatments for sickle-cell disease. The big focus is on Casgevy, as it is derived from the gene-editing tool CRISPR. Co-developed by Vertex Pharmaceuticals and CRISPR Therapeutics, Casgevy is different from most genetic editing tools in that it works after the embryo stage, so it can be taken as an adult. Once in the blood stream, it will modify and reform red blood cells into their proper shape. This allows them to properly carry oxygen, and hopefully provide relief to those victimized by sickle-cell disease. There are some mild side effects (mouth sores, etc.), but Vertex said they were ready to roll it out immediately. They currently have nine authorized treatment centers across the US, but more are scheduled to be following.

The Next Steps

This event marks a seismic shift in the medical world. Not only is it significant for those with sickle-cell disease, but with the health community at large. Now that we’ve used gene editing to treat this illness, what’s next? Down syndrome, cystic fibrosis; the list of genetic diseases goes on and on. At long last, there is hope for people suffering from them. Change is on the horizon.



Works Cited

Farrell, James. “FDA Approves New CRISPR Gene-Editing Treatment.” Forbes, 16
Jan. 2024,
fda-approves-new-crispr-gene-editing-treatment/?sh=5d0e814bb492. Accessed
17 Jan. 2024.

Pflaum, Carly. “FDA Approves First Gene Therapies to Treat Patients with Sickle
Cell Disease.” U.S. Food and Drug Administration, 8 Dec. 2023,

Leave a Comment
More to Discover
About the Contributor
Gavin Magnuson
Gavin Magnuson, Staff Writer and Contributor
I'm Gavin Magnuson, and I'm on the Owl Team in 7th grade. I like math and science, and I do Science Olympiad in addition to the Colt. In my free time, I like to read and write; my favorite book is Legendborn by Tracy Deonn.  I'm fascinated with the natural world, and I want to be a marine biologist when I grow up.

Comments (0)

All The Colt Picks Reader Picks Sort: Newest

Your email address will not be published. Required fields are marked *